Drug Trial Radar · NCT06285214
Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome
Last checked: Nov 20, 2026Latest source record: Mar 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
47
Actual
Start
May 26, 2022
Primary completion
Jan 28, 2025
Study completion Jan 28, 2025
Sponsor
- Lead sponsor
- Imbrium TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Purdue Pharma LP
- First posted
- Feb 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with interstitial cystitis/bladder pain syndrome, compared to placebo.
Conditions
- Interstitial Cystitis/Bladder Pain Syndrome
Interventions
V117957Drug
V117957 1 mg - 1 tablet taken orally at bedtime.
PlaceboDrug
Placebo to match V117957 tablets - 1 tablet taken orally at bedtime.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline for Worst Bladder Pain/Discomfort Scores Overnight / Over-the-dayTime frame: Assessed at Baseline, Weeks 2 and 8. Change from Baseline to Week 2 (Period 1) and Week 8 (Period 2) reported.
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Urology Centers of Alabama, PC
Homewood, Alabama
Urological Associates of Southern Arizona
Tucson, Arizona
Applied Research Center of Arkansas
Little Rock, Arkansas
Investigational Site
Escondido, California
Urology Group of Southern California
Los Angeles, California
Hope Clinical Research, LLC
Los Angeles, California
Tri Valley Urology Medical Group
Murrieta, California
Accel Research Sites
DeLand, Florida
Accel Research Site - Neurostudies
Decatur, Georgia
Providea Health Partners LLC
Evergreen Park, Illinois
Otrimed Clinical Research
Edgewood, Kentucky
Southern Clinical Research Associates
Metairie, Louisiana
Ochsner Louisiana State University Health Shreveport - Regional University
Shreveport, Louisiana
Chesapeake Urology Research Associates
Owings Mills, Maryland
Boston Clinical Trials
Boston, Massachusetts
Bay State Clinical Trials, Inc.
Watertown, Massachusetts
Revive Research Institute, Inc
Dearborn Heights, Michigan
CentraCare - Urology Clinic
Sartell, Minnesota
Adult & Pediatric Urology P.C.
Omaha, Nebraska
AccuMed Research Associates
Garden City, New York
Manhattan Medical Research Practice
New York, New York
Unified Women's Clinical Research-Lyndhurst Clinical Research
Winston-Salem, North Carolina
MetroHealth System
Cleveland, Ohio
MidLantic Urology
Bala-Cynwyd, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.